# Case Report: A rare case of long-term survival in primary pulmonary adenoid cystic carcinoma with bilateral renal and chest wall metastases

**Authors:** Chunlin Huang, Zhihua Ye, Xiaoyun Zhou, Junkai Zhang

PMC · DOI: 10.3389/fonc.2026.1732593 · Frontiers in Oncology · 2026-03-04

## TL;DR

A rare case of long-term survival in a patient with primary pulmonary adenoid cystic carcinoma and metastases to the kidneys and chest wall is reported.

## Contribution

This is the first reported case of PACC with concurrent bilateral renal and chest wall metastases and long-term survival.

## Key findings

- The patient survived over 11 years with multimodal therapy despite metastases.
- Sequential treatments including radiotherapy, chemotherapy, and immunotherapy reduced the chest wall mass.
- Ultrasound-guided ablation led to no viability in bilateral renal tumors.

## Abstract

Primary pulmonary adenoid cystic carcinoma (PACC) is an exceedingly rare malignant lung tumor. We report an extremely rare case of a 38-year-old female. In 2013, a computed tomography (CT) scan suggested lung cancer in the left upper lobe, and a percutaneous biopsy confirmed PACC pathologically. She underwent surgical resection followed by postoperative adjuvant chemotherapy in the same year, with no recurrence during the 5-year post-operative follow-up. In December 2019, follow-up CT revealed bilateral renal metastases. Subsequently, in 2021, chest wall metastases developed. After sequential radiotherapy, chemotherapy, and combined immunotherapy, the chest wall mass was significantly reduced. During this period, multiple immune-related adverse events (irAEs) occurred. Upon progression of the renal metastases in 2024, ultrasound-guided ablation was performed. Subsequent re-evaluations showed essentially no viability in the bilateral renal tumors, and the chest wall mass remained stable. This patient was diagnosed with PACC in 2013. As of September 2025, her overall survival (OS) has exceeded 11 years. The successful management of this case is attributed to multimodal therapy. To date, no cases of PACC with concurrent bilateral renal and chest wall metastases have been reported, thus providing a valuable reference for the diagnosis and treatment of PACC.

## Linked entities

- **Diseases:** lung cancer (MONDO:0005138)

## Full-text entities

- **Diseases:** renal tumors (MESH:D007680), metastases (MESH:D009362), lung cancer (MESH:D008175), PACC (MESH:D003528)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12995776/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12995776/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12995776/full.md

---
Source: https://tomesphere.com/paper/PMC12995776